David Craik
The University of Queensland, QLD, Australia
- This delegate is presenting an abstract at this event.
David Craik is a NHMRC Senior Principal Research Fellow at the Institute for Molecular Bioscience, The University of Queensland. He obtained his PhD in organic chemistry from La Trobe University in Melbourne, Australia (1981) and undertook postdoctoral studies at Florida State and Syracuse Universities before taking up a lectureship at the Victorian College of Pharmacy in 1983. He was appointed Professor of Medicinal Chemistry and head of School in 1988. He moved to University of Queensland in 1995 to set up a new biomolecular NMR laboratory. His research focuses on the application of NMR in drug design, and on toxins, including conotoxins. His group has a particular focus on structural studies of disulfide-rich proteins, and on the discovery and applications of circular proteins and novel protein topologies. He has trained more than 60 PhD students and is the author of 500 scientific publications.
Presentations this author is a contributor to:
Development of cyclic-peptide scaffolds to target intracellular protein-protein interactions in cancer cells (#120)
8:00 PM
Gregoire Philippe
Poster Session 1
Design of ultra-stable, bioactive cyclic peptides (#100)
8:00 PM
Quentin Kaas
Poster Session 1
Harnessing structural conservation among serine proteases to engineer targeted inhibitors using a plant-derived cyclic peptide scaffold (#143)
8:00 PM
Simon de Veer
Poster Session 2
Inhibitory effects of substrate-based BCR-ABL1 kinase inhibitors on drug-resistant chronic myeloid leukaemia cell lines (#155)
8:00 PM
Yen-Hua Huang
Poster Session 2
Backbone cyclization of analgesic conotoxin GeXIVA facilitates direct folding of the ribbon isomer (#203)
8:00 PM
Xiaosa Wu
Poster Session 2